PMID: 25725228Mar 1, 2015Paper

Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis

Discovery Medicine
James L Kuhlen, Yamini V Virkud

Abstract

Idiopathic anaphylaxis (IA) is a life-threatening allergic disease and the most common diagnosis given to patients following an anaphylactic event. The inability of the healthcare provider and the patient to identify the trigger for anaphylaxis makes standard allergen avoidance measures ineffectual. IA is diagnosed after other causes of anaphylaxis have been excluded. Mast cell activation syndromes (MCAS), mastocytosis, IgE to galactose-alpha-1,3-galactose (α-gal), and certain medications have recently been recognized as causes of anaphylaxis that were previously labeled idiopathic. This review will describe the epidemiology and proposed theories of pathogenesis for IA, its diagnostic approach, its clinical management, and examine newly recognized disorders that were previously labeled as idiopathic anaphylaxis.

Related Concepts

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
R PattersonM A Shaughnessy
The Medical Clinics of North America
T P Atkinson, M A Kaliner
Clinical Reviews in Allergy & Immunology
Joanne K Simpson, Dean D Metcalfe
The New England Journal of Medicine
Dilani F Arnold, Siraj A Misbah
© 2022 Meta ULC. All rights reserved